-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Sorrento Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2015 to Q2 2023.
- Sorrento Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2023 was 551M shares, a 36.9% increase year-over-year.
- Sorrento Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 419M shares, a 42.3% increase from 2021.
- Sorrento Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 295M shares, a 28.3% increase from 2020.
- Sorrento Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 230M shares, a 63.6% increase from 2019.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)